Symbiomix Therapeutics symbiomix.com


Public list: BIO 2016 (619) Womens Health Startups (448) Pharma Startups (4732)

Symbiomix is a held biopharmaceutical company with a focus on women's health. The company's lead product, SYM-1219, is a new anti-infective drug being studied as the first oral one-and-done treatment in the United States for bacterial vaginosis (BV), a common but underappreciated gynecological infection that greatly increases the risk of serious health problems.

Symbiomix is a held biopharmaceutical company with a focus on women's health. The company's lead product, SYM-1219, is a new anti-infective drug being studied as the first oral one-and-done treatment in the United States for bacterial vaginosis (BV),...Show all

Company (Acquired)

Phone: 609-722-7250

Fax:

105 Lock Street
Suite 409
Newark, 07103
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Symbiomix Therapeutics $46.6M Oct 11, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Symbiomix Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
OrbiMed AdvisorsVenture CapitalNew York, New York, United StatesSeries A - III, Series A - II, Series A
F-Prime CapitalVenture CapitalCambridge, Massachusetts, United StatesSeries A - III, Series A - II, Series A
HBM PartnersPrivate EquityZug, SwitzerlandSeries A - II
Square 1 BankBankDurham, North Carolina, United StatesSeries A - II
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Novel nitroimidazole formulations and uses thereof Jun 01, 2016 Application
Secnidazole for use in the treatment of bacterial vaginosis Sep 04, 2015 Application